{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:42:11Z","timestamp":1789404131882,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41401-025-01587-7","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T03:55:31Z","timestamp":1749614131000},"page":"2938-2950","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["YOD1 mediates isoproterenol-induced cardiac remodeling by deubiquitinating PKM2 and reducing PKM2 tetramerization in cardiomyocytes"],"prefix":"10.1038","volume":"46","author":[{"given":"Qing-song","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-qiang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-chen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-fu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin-yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-ni","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-qian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-chen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding-dao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"1587_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 2018;15:387\u2013407.","journal-title":"Nat Rev Cardiol"},{"key":"1587_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","volume":"113","author":"T Doenst","year":"2013","unstructured":"Doenst T, Nguyen TD, Abel ED. Cardiac metabolism in heart failure implications beyond ATP production. Circ Res. 2013;113:709\u201324.","journal-title":"Circ Res"},{"key":"1587_CR3","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1161\/CIRCRESAHA.113.301651","volume":"113","author":"M Luo","year":"2013","unstructured":"Luo M, Anderson ME. Mechanisms of altered Ca2+ handling in heart failure. Circ Res. 2013;113:690\u2013708.","journal-title":"Circ Res"},{"key":"1587_CR4","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nm.4179","volume":"22","author":"ZH Wang","year":"2016","unstructured":"Wang ZH, Zhang XJ, Ji YX, Zhang P, Deng KQ, Gong J, et al. The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy. Nat Med. 2016;22:1131\u20139.","journal-title":"Nat Med"},{"key":"1587_CR5","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","volume":"20","author":"D Popovic","year":"2014","unstructured":"Popovic D, Vucic D, Dikic I. Ubiquitination in disease pathogenesis and treatment. Nat Med. 2014;20:1242\u201353.","journal-title":"Nat Med"},{"key":"1587_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrd.2017.152","volume":"17","author":"JA Harrigan","year":"2018","unstructured":"Harrigan JA, Jacq X, Martin NM, Jackson SP. Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat Rev Drug Discov. 2018;17:57\u201377.","journal-title":"Nat Rev Drug Discov"},{"key":"1587_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1146\/annurev-biochem-061516-044916","volume":"86","author":"TET Mevissen","year":"2017","unstructured":"Mevissen TET, Komander D. Mechanisms of deubiquitinase specificity and regulation. Annu Rev Biochem. 2017;86:159\u201392.","journal-title":"Annu Rev Biochem"},{"key":"1587_CR8","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1161\/CIRCRESAHA.122.321849","volume":"132","author":"BZ Ye","year":"2023","unstructured":"Ye BZ, Zhou H, Chen YH, Luo W, Lin WT, Zhao Y, et al. USP25 ameliorates pathological cardiac hypertrophy by stabilizing SERCA2a in cardiomyocytes. Circ Res. 2023;132:465\u201380.","journal-title":"Circ Res"},{"key":"1587_CR9","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1161\/HYPERTENSIONAHA.116.07562","volume":"68","author":"XY Ying","year":"2016","unstructured":"Ying XY, Zhao YC, Yao TB, Yuan AC, Xu LW, Gao LC, et al. Novel protective role for ubiquitin-specific protease 18 in pathological cardiac remodeling. Hypertension. 2016;68:1160\u201370.","journal-title":"Hypertension"},{"key":"1587_CR10","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1161\/HYPERTENSIONAHA.116.07392","volume":"67","author":"B He","year":"2016","unstructured":"He B, Zhao YC, Gao LC, Ying XY, Xu LW, Su YY, et al. Ubiquitin-specific protease 4 is an endogenous negative regulator of pathological cardiac hypertrophy. Hypertension. 2016;67:1237\u201348.","journal-title":"Hypertension"},{"key":"1587_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s13046-023-02781-3","volume":"42","author":"ZT Han","year":"2023","unstructured":"Han ZT, Jia Q, Zhang J, Chen MM, Wang LN, Tong K, et al. Deubiquitylase YOD1 regulates CDK1 stability and drives triple-negative breast cancer tumorigenesis. J Exp Clin Cancer Res. 2023;42:228.","journal-title":"J Exp Clin Cancer Res"},{"key":"1587_CR12","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1016\/j.apsb.2021.10.020","volume":"12","author":"XJ Shao","year":"2022","unstructured":"Shao XJ, Chen YQ, Wang W, Du WX, Zhang XY, Cai MY, et al. Blockade of deubiquitinase YOD1 degrades oncogenic PML\/RAR\u03b1 and eradicates acute promyelocytic leukemia cells. Acta Pharm Sin B. 2022;12:1856\u201370.","journal-title":"Acta Pharm Sin B"},{"key":"1587_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02616-9","volume":"22","author":"ZS Zhang","year":"2022","unstructured":"Zhang ZS, Zhao WX, Li YM, Li Y, Cheng HZ, Zheng LY, et al. YOD1 serves as a potential prognostic biomarker for pancreatic cancer. Cancer Cell Int. 2022;22:20.","journal-title":"Cancer Cell Int"},{"key":"1587_CR14","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/s41401-024-01278-9","volume":"45","author":"WT Lin","year":"2024","unstructured":"Lin WT, Jiang YC, Mei YL, Chen YH, Zheng ZZ, Han X, et al. Endothelial deubiquinatase YOD1 mediates Ang II-induced vascular endothelial-mesenchymal transition and remodeling by regulating \u03b2-catenin. Acta Pharmacol Sin. 2024;45:1618\u201331.","journal-title":"Acta Pharmacol Sin."},{"key":"1587_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1161\/CIRCULATIONAHA.117.030811","volume":"138","author":"L Zhou","year":"2018","unstructured":"Zhou L, Miao K, Yin BJ, Li HP, Fan JH, Zhu YZ, et al. Cardioprotective role of myeloid-derived suppressor cells in heart failure. Circulation. 2018;138:181\u201397.","journal-title":"Circulation"},{"key":"1587_CR16","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1161\/CIRCULATIONAHA.118.035420","volume":"138","author":"S Park","year":"2018","unstructured":"Park S, Ranjbarvaziri S, Lay FD, Zhao P, Miller MJ, Dhaliwal JS, et al. Genetic regulation of fibroblast activation and proliferation in cardiac fibrosis. Circulation. 2018;138:1224\u201335.","journal-title":"Circulation"},{"key":"1587_CR17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2147\/DDDT.S195412","volume":"13","author":"BZ Ye","year":"2019","unstructured":"Ye BZ, Chen XD, Dai SS, Han JB, Liang XH, Lin S, et al. Emodin alleviates myocardial ischemia\/reperfusion injury by inhibiting gasdermin D-mediated pyroptosis in cardiomyocytes. Drug Des Devel Ther. 2019;13:975\u201390.","journal-title":"Drug Des Devel Ther"},{"key":"1587_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo0987","volume":"8","author":"SY Gao","year":"2022","unstructured":"Gao SY, Li XH, Jiang QY, Liang Q, Zhang FX, Li SL, et al. PKM2 promotes pulmonary fibrosis by stabilizing TGF-\u03b21 receptor I and enhancing TGF-\u03b21 signaling. Sci Adv. 2022;8:eabo0987.","journal-title":"Sci Adv"},{"key":"1587_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04780-6","volume":"21","author":"LZ Guo","year":"2023","unstructured":"Guo LZ, Wang L, Qin G, Zhang JJ, Peng J, Li LY, et al. M-type pyruvate kinase 2 (PKM2) tetramerization alleviates the progression of right ventricle failure by regulating oxidative stress and mitochondrial dynamics. J Transl Med. 2023;21:888.","journal-title":"J Transl Med"},{"key":"1587_CR20","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1161\/CIRCULATIONAHA.123.064121","volume":"147","author":"YS Tang","year":"2023","unstructured":"Tang YS, Feng MY, Su Y, Ma T, Zhang HJ, Wu HC, et al. Jmjd4 facilitates Pkm2 degradation in cardiomyocytes and is protective against dilated cardiomyopathy. Circulation. 2023;147:1684\u2013704.","journal-title":"Circulation"},{"key":"1587_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.molcel.2009.09.016","volume":"36","author":"R Ernst","year":"2009","unstructured":"Ernst R, Mueller B, Ploegh HL, Schlieker C. The otubain YOD1 is a deubiquitinating enzyme that associates with p97 to facilitate protein dislocation from the ER. Mol Cell. 2009;36:28\u201338.","journal-title":"Mol Cell"},{"key":"1587_CR22","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1136\/gutjnl-2021-325150","volume":"71","author":"JH Rao","year":"2022","unstructured":"Rao JH, Wang H, Ni M, Wang Z, Wang ZY, Wei S, et al. FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2. Gut. 2022;71:2539\u201350.","journal-title":"Gut"},{"key":"1587_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41388-021-02071-2","volume":"41","author":"SY Yu","year":"2022","unstructured":"Yu SY, Zang WC, Qiu YC, Liao LM, Zheng XF. Deubiquitinase OTUB2 exacerbates the progression of colorectal cancer by promoting PKM2 activity and glycolysis. Oncogene. 2022;41:46\u201356.","journal-title":"Oncogene"},{"key":"1587_CR24","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1002\/1878-0261.13076","volume":"15","author":"TS Sun","year":"2021","unstructured":"Sun TS, Liu ZN, Bi FF, Yang Q. Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2. Mol Oncol. 2021;15:3639\u201358.","journal-title":"Mol Oncol"},{"key":"1587_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.molcel.2016.09.014","volume":"64","author":"F Ohtake","year":"2016","unstructured":"Ohtake F, Saeki Y, Ishido S, Kanno J, Tanaka K. The K48-K63 branched ubiquitin chain regulates NF-\u03baB signaling. Mol Cell. 2016;64:251\u201366.","journal-title":"Mol Cell"},{"key":"1587_CR26","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.it.2021.12.005","volume":"43","author":"C Madiraju","year":"2022","unstructured":"Madiraju C, Novack JP, Reed JC, Matsuzawa S. K63 ubiquitination in immune signaling. Trends Immunol. 2022;43:148\u201362.","journal-title":"Trends Immunol"},{"key":"1587_CR27","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nm.4328","volume":"23","author":"W Qi","year":"2017","unstructured":"Qi W, Keenan HA, Li Q, Ishikado A, Kannt A, Sadowski T, et al. Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction. Nat Med. 2017;23:753\u201362.","journal-title":"Nat Med"},{"key":"1587_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cmet.2014.12.005","volume":"21","author":"EM Palsson-McDermott","year":"2015","unstructured":"Palsson-McDermott EM, Curtis AM, Goel G, Lauterbach MAR, Sheedy FJ, Gleeson LE, et al. Pyruvate kinase M2 regulates Hif-1\u03b1 activity and IL-1\u03b2 induction and is a critical determinant of the Warburg effect in LPS-activated macrophages. Cell Metab. 2015;21:65\u201380.","journal-title":"Cell Metab"},{"key":"1587_CR29","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1126\/science.1211485","volume":"334","author":"D Anastasiou","year":"2011","unstructured":"Anastasiou D, Poulogiannis G, Asara JM, Boxer MB, Jiang JK, Shen M, et al. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science. 2011;334:1278\u201383.","journal-title":"Science"},{"key":"1587_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau8866","volume":"11","author":"B Saleme","year":"2019","unstructured":"Saleme B, Gurtu V, Zhang YN, Kinnaird A, Boukouris AE, Gopal K, et al. Tissue-specific regulation of p53 by PKM2 is redox dependent and provides a therapeutic target for anthracycline-induced cardiotoxicity. Sci Transl Med. 2019;11:eaau8866.","journal-title":"Sci Transl Med"},{"key":"1587_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax4826","volume":"6","author":"HL Bi","year":"2020","unstructured":"Bi HL, Zhang XL, Zhang YL, Xie X, Xia YL, Du J, et al. The deubiquitinase UCHL1 regulates cardiac hypertrophy by stabilizing epidermal growth factor receptor. Sci Adv. 2020;6:eaax4826.","journal-title":"Sci Adv"},{"key":"1587_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1790","volume":"14","author":"JF Qian","year":"2024","unstructured":"Qian JF, Wang QY, Xu JC, Liang SQ, Zheng QS, Guo XC, et al. Macrophage OTUD1-CARD9 axis drives isoproterenol-induced inflammatory heart remodelling. Clin Transl Med. 2024;14:e1790.","journal-title":"Clin Transl Med"},{"key":"1587_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.nbd.2018.01.006","volume":"112","author":"K Tanji","year":"2018","unstructured":"Tanji K, Mori F, Miki Y, Utsumi J, Sasaki H, Kakita A, et al. YOD1 attenuates neurogenic proteotoxicity through its deubiquitinating activity. Neurobiol Dis. 2018;112:14\u201323.","journal-title":"Neurobiol Dis"},{"key":"1587_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.semcdb.2015.08.004","volume":"43","author":"WJ Israelsen","year":"2015","unstructured":"Israelsen WJ, Vander Heiden MG. Pyruvate kinase: function, regulation and role in cancer. Semin Cell Dev Biol. 2015;43:43\u201351.","journal-title":"Semin Cell Dev Biol"},{"key":"1587_CR35","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.biocel.2010.02.005","volume":"43","author":"S Mazurek","year":"2011","unstructured":"Mazurek S. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Int J Biochem Cell Biol. 2011;43:969\u201380.","journal-title":"Int J Biochem Cell Biol"},{"key":"1587_CR36","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s13238-019-0618-z","volume":"10","author":"T Li","year":"2019","unstructured":"Li T, Han JB, Jia LJ, Hu X, Chen LQ, Wang YG. PKM2 coordinates glycolysis with mitochondrial fusion and oxidative phosphorylation. Protein Cell. 2019;10:583\u201394.","journal-title":"Protein Cell"},{"key":"1587_CR37","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00018-024-05253-9","volume":"81","author":"YZ Du","year":"2024","unstructured":"Du YZ, Li JL, Dai Z, Chen YX, Zhao Y, Liu XM, et al. Pyruvate kinase M2 sustains cardiac mitochondrial quality surveillance in septic cardiomyopathy by regulating prohibitin 2 abundance via S91 phosphorylation. Cell Mol Life Sci. 2024;81:983\u201393.","journal-title":"Cell Mol Life Sci"},{"key":"1587_CR38","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1161\/CIRCULATIONAHA.121.053575","volume":"144","author":"S Ranjbarvaziri","year":"2021","unstructured":"Ranjbarvaziri S, Kooiker KB, Ellenberger M, Fajardo G, Zhao MM, Vander Roest AS, et al. Altered cardiac energetics and mitochondrial dysfunction in hypertrophic cardiomyopathy. Circulation. 2021;144:1714\u201331.","journal-title":"Circulation"},{"key":"1587_CR39","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/s41418-020-00669-9","volume":"28","author":"L Hauck","year":"2021","unstructured":"Hauck L, Dadson K, Chauhan S, Grothe D, Billia F. Inhibiting the Pkm2\/b-catenin axis drives in vivo replication of adult cardiomyocytes following experimental MI. Cell Death Differ. 2021;28:1398\u2013417.","journal-title":"Cell Death Differ"},{"key":"1587_CR40","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.024854","volume":"11","author":"L Ni","year":"2022","unstructured":"Ni L, Lin BW, Hu LJ, Zhang RY, Fu FM, Shen MT, et al. Pyruvate kinase M2 protects heart from pressure overload-induced heart failure by phosphorylating RAC1. J Am Heart Assoc. 2022;11:e024854.","journal-title":"J Am Heart Assoc"},{"key":"1587_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abm3565","volume":"14","author":"MA Lorenzana-Carrillo","year":"2022","unstructured":"Lorenzana-Carrillo MA, Gopal K, Byrne NJ, Tejay S, Saleme B, Das SK, et al. TRIM35-mediated degradation of nuclear PKM2 destabilizes GATA4\/6 and induces P53 in cardiomyocytes to promote heart failure. Sci Transl Med. 2022;14:eabm3565.","journal-title":"Sci Transl Med"},{"key":"1587_CR42","doi-asserted-by":"publisher","first-page":"C186","DOI":"10.1107\/S010876730509210X","volume":"61","author":"JD Dombrauckas","year":"2005","unstructured":"Dombrauckas JD, Santarsiero BD, Mesecar AD. Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. Acta Crystallogr Sect A. 2005;61:C186\u2013C186.","journal-title":"Acta Crystallogr Sect A"},{"key":"1587_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41421-023-00633-0","volume":"10","author":"LJ Liang","year":"2024","unstructured":"Liang LJ, Yang FY, Wang D, Zhang YF, Yu H, Wang Z, et al. CIP2A induces PKM2 tetramer formation and oxidative phosphorylation in non-small cell lung cancer. Cell Discov. 2024;10:13.","journal-title":"Cell Discov"},{"key":"1587_CR44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11481-024-10138-6","volume":"19","author":"HY Zhu","year":"2024","unstructured":"Zhu HY, Zhang HW, Zhao XJ, Zhang LY, Liu X, Zhang ZY, et al. Tetramerization of PKM2 alleviates traumatic brain injury by ameliorating mitochondrial damage in microglia. J Neuroimmune Pharmacol. 2024;19:48.","journal-title":"J Neuroimmune Pharmacol."},{"key":"1587_CR45","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jacbts.2022.01.005","volume":"7","author":"T Shimauchi","year":"2022","unstructured":"Shimauchi T, Boucherat O, Yokokawa T, Grobs Y, Wu WH, Orcholski M, et al. PARP1-PKM2 axis mediates right ventricular failure associated with pulmonary arterial hypertension. JACC Basic Transl Sci. 2022;7:384\u2013403.","journal-title":"JACC Basic Transl Sci"},{"key":"1587_CR46","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1073\/pnas.77.6.3484","volume":"77","author":"JG Burr","year":"1980","unstructured":"Burr JG, Dreyfuss G, Penman S, Buchanan JM. Association of the src gene product of Rous sarcoma virus with cytoskeletal structures of chicken embryo fibroblasts. Proc Natl Acad Sci USA. 1980;77:3484\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1587_CR47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1126\/scisignal.2000431","volume":"2","author":"T Hitosugi","year":"2009","unstructured":"Hitosugi T, Kang SK, Heiden MGV, Chung TW, Elf S, Lythgoe K, et al. Tyrosine phosphorylation inhibits PKM2 to promote the warburg effect and tumor growth. Sci Signal. 2009;2:8.","journal-title":"Sci Signal"},{"key":"1587_CR48","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1073\/pnas.96.4.1291","volume":"96","author":"W Zwerschke","year":"1999","unstructured":"Zwerschke W, Mazurek S, Massimi P, Banks L, Eigenbrodt E, Jansen-D\u00fcrr P. Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein. Proc Natl Acad Sci USA. 1999;96:1291\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1587_CR49","doi-asserted-by":"publisher","first-page":"13732","DOI":"10.1073\/pnas.1704145115","volume":"114","author":"Y Wang","year":"2017","unstructured":"Wang Y, Liu J, Jin X, Zhang DP, Li DX, Hao FQ, et al. O-GlcNAcylation destabilizes the active tetrameric PKM2 to promote the Warburg effect. Proc Natl Acad Sci USA. 2017;114:13732\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1587_CR50","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1158\/0008-5472.CAN-15-2498","volume":"76","author":"SH Park","year":"2016","unstructured":"Park SH, Ozden O, Liu GX, Song HY, Zhu YM, Yan YF, et al. SIRT2-mediated deacetylation and tetramerization of pyruvate kinase directs glycolysis and tumor growth. Cancer Res. 2016;76:3802\u201312.","journal-title":"Cancer Res"},{"key":"1587_CR51","volume":"15","author":"RH Wang","year":"2024","unstructured":"Wang RH, Chen PR, Chen YT, Chen YC, Chu YH, Chien CC, et al. Hydrogen sulfide coordinates glucose metabolism switch through destabilizing tetrameric pyruvate kinase M2. Nat Commun. 2024;15:18.","journal-title":"Nat Commun"},{"key":"1587_CR52","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cmet.2019.10.015","volume":"31","author":"S Angiari","year":"2020","unstructured":"Angiari S, Runtsch MC, Sutton CE, Palsson-McDermott EM, Kelly B, Rana N, et al. Pharmacological activation of pyruvate kinase M2 inhibits CD4+ T cell pathogenicity and suppresses autoimmunity. Cell Metab. 2020;31:391\u2013405.e398.","journal-title":"Cell Metab"},{"key":"1587_CR53","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41590-019-0363-8","volume":"20","author":"SA Dick","year":"2019","unstructured":"Dick SA, Macklin JA, Nejat S, Momen A, Clemente-Casares X, Althagafi MG, et al. Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction. Nat Immunol. 2019;20:664.","journal-title":"Nat Immunol"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01587-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01587-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01587-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:02:45Z","timestamp":1761292965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01587-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1587"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01587-7","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"20 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}